Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

MEDRELEAF CORP T.LEAF

"MedReleaf Corp is engaged in the production and sale of cannabis for medical purposes as regulated by the ACMPR, pursuant to its Licences and, in particular, its Markham Commercial Licence."


TSX:LEAF - Post by User

Comment by Analystguyon May 23, 2018 2:04pm
82 Views
Post# 28070784

RE:RE:RE:Need for Special Meeting Vote

RE:RE:RE:Need for Special Meeting Vote
My preference would be to hope for Canopy as well. I worry that ACB's cost side is becoming too bloated which will negatively impact EPS. LEAF and WEED have similar risk adjusted rates of return whereas ACB;s risk adjusted rate of return is much lower.
<< Previous
Bullboard Posts
Next >>